Van Hoogevest; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Van Hoogevest; Peter.The latest application filed is for "dissolution composition for examining drug solubility".
- Van Hoogevest; Peter - Neustadt an der Weinstrasse DE
- Van Hoogevest; Peter - Bubendorf CH
- Van HoogeVest; Peter - Neustadt/Weinstr DE
- Van Hoogevest; Peter - Muttenz N/A CH
- Van Hoogevest; Peter - Budendorf CH
- van Hoogevest; Peter - Riehen CH
| Patent | Date |
|---|---|
| Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative Grant 10,603,384 - Paulus , et al. | 2020-03-31 |
| Dissolution Composition For Examining Drug Solubility App 20160299113 - Leigh; Steve ; et al. | 2016-10-13 |
| Pharmaceutical Composition Containing An Antivirally Active Dihydroquinazoline Derivative App 20150133461 - Paulus; Kerstin ; et al. | 2015-05-14 |
| Formulation for treatment of vaginal dryness Grant 9,005,597 - Hansen , et al. April 14, 2 | 2015-04-14 |
| Pharmaceutical Compositions Of Pyridinium And Quinolinium Derivatives App 20150037397 - Palacios Izquierdo; Beatriz ; et al. | 2015-02-05 |
| Dissolution composition for examining drug solubility Grant 8,889,189 - Leigh , et al. November 18, 2 | 2014-11-18 |
| Pharmaceutical composition including a DHA ester to be administered parenterally Grant 8,753,652 - Leverd , et al. June 17, 2 | 2014-06-17 |
| Direct dissolution Grant 8,632,832 - Leigh , et al. January 21, 2 | 2014-01-21 |
| Dissolution Composition For Examining Drug Solubility App 20130055831 - Leigh; Steve ; et al. | 2013-03-07 |
| Dissolution composition for examining drug solubility Grant 8,287,907 - Leigh , et al. October 16, 2 | 2012-10-16 |
| Formulation For Treatment Of Vaginal Dryness App 20110262381 - Hansen; Ketil Andre ; et al. | 2011-10-27 |
| Method Of Solubilizing Biologically Active Compounds App 20110244028 - Leigh; Steve ; et al. | 2011-10-06 |
| Organic Compounds App 20110124691 - van Hoogevest; Peter | 2011-05-26 |
| Crystal forms of astaxanthin Grant 7,563,935 - Leigh , et al. July 21, 2 | 2009-07-21 |
| Dissolution Composition For Examining Drug Solubility App 20090145248 - Leigh; Steve ; et al. | 2009-06-11 |
| Direct dissolution App 20080311267 - Leigh; Steve ; et al. | 2008-12-18 |
| Crystal Forms Of Astaxanthin App 20080234521 - LEIGH; Steve ; et al. | 2008-09-25 |
| Organic Compounds App 20080221065 - van Hoogevest; Peter | 2008-09-11 |
| Lipophilic compositions App 20060286169 - Leigh; Mathew Louis, Stephen ; et al. | 2006-12-21 |
| Microdispersion and method of producing same App 20060233846 - Leigh; Steve ; et al. | 2006-10-19 |
| Ambiphilic porous matrix App 20060153886 - Leigh; Mathew Louis Steven ; et al. | 2006-07-13 |
| Marine lipid compositions App 20060128665 - Leigh; Steve ; et al. | 2006-06-15 |
| Organic compounds App 20060127423 - van Hoogevest; Peter | 2006-06-15 |
| Organic compounds Grant 6,683,100 - van Hoogevest January 27, 2 | 2004-01-27 |
| Parenteral Formulations Comprising Carbamazepine Or Its Derivatives App 20020055503 - Van Hoogevest, Peter | 2002-05-09 |
| Nanosuspensions for intravenous administration Grant 5,726,164 - Weder , et al. March 10, 1 | 1998-03-10 |
| Parenterally administrable liposome formulation comprising synthetic lipids Grant 5,466,468 - Schneider , et al. Nov | 1995-11-14 |
| Parenterally administerable liposome formulation comprising synthetic lipid Grant 5,270,053 - Schneider , et al. December 14, 1 | 1993-12-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 